Pages that link to "Q33859904"
Jump to navigation
Jump to search
The following pages link to The selective mGlu2/3 receptor agonist LY354740 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal (Q33859904):
Displayed 31 items.
- Glutamatergic substrates of drug addiction and alcoholism (Q24648924) (← links)
- Selective agonist of group II glutamate metabotropic receptors, LY354740, inhibits tolerance to analgesic effects of morphine in mice (Q24674933) (← links)
- Effects of LY354740, a novel glutamatergic metabotropic agonist, on nonhuman primate hypothalamic-pituitary-adrenal axis and noradrenergic function (Q28295900) (← links)
- Regulation of neurotransmitter release by metabotropic glutamate receptors (Q28506056) (← links)
- Metabotropic glutamate receptors: from the workbench to the bedside (Q30448778) (← links)
- Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge (Q33187534) (← links)
- Pharmacological agents acting at subtypes of metabotropic glutamate receptors (Q33756933) (← links)
- Effects of the mGlu2/3 agonist LY379268 and the mGlu5 antagonist MTEP on ethanol seeking and reinforcement are differentially altered in rats with a history of ethanol dependence (Q33788180) (← links)
- Endogenous opiates: 1999. (Q34126256) (← links)
- Glutamate receptors and nociception: implications for the drug treatment of pain (Q34314547) (← links)
- Pharmacotherapies in the management of obsessive-compulsive disorder (Q34547177) (← links)
- In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders (Q34612242) (← links)
- Role of corticostriatal circuits in context-induced reinstatement of drug seeking (Q35185615) (← links)
- The neurobiology and control of anxious states (Q35202929) (← links)
- Glutamate receptor subunit expression in the rhesus macaque locus coeruleus (Q36122888) (← links)
- Acute and chronic heroin dependence in mice: contribution of opioid and excitatory amino acid receptors (Q36768732) (← links)
- Role of the glutamatergic system in nicotine dependence : implications for the discovery and development of new pharmacological smoking cessation therapies (Q37242594) (← links)
- The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence (Q38025454) (← links)
- Systemic pre-treatment with a group II mGlu agonist, LY379268, reduces hyperalgesia in vivo (Q41871183) (← links)
- Inhibition of morphine withdrawal by the NMDA receptor antagonist MK-801 in rat is age-dependent (Q43579998) (← links)
- Olanzapine activates the rat locus coeruleus: in vivo electrophysiology and c-Fos immunoreactivity (Q43766052) (← links)
- Stereoselective synthesis of 2-amino-3-fluoro bicyclo[3.1.0]hexane-2,6-dicarboxylic acid (Q43821581) (← links)
- Metabotropic glutamate receptor 2/3-dependent long-term depression in the nucleus accumbens is blocked in morphine withdrawn mice. (Q44243012) (← links)
- Morphine tolerance and reward but not expression of morphine dependence are inhibited by the selective glutamate carboxypeptidase II (GCP II, NAALADase) inhibitor, 2-PMPA. (Q44357517) (← links)
- A role of ventral tegmental area glutamate in contextual cue-induced relapse to heroin seeking. (Q45163165) (← links)
- Presynaptic homeostatic plasticity rescues long-term depression after chronic Delta 9-tetrahydrocannabinol exposure. (Q46851483) (← links)
- Potentiation of synaptic strength and intrinsic excitability in the nucleus accumbens after 10 days of morphine withdrawal (Q48629573) (← links)
- Mapping of c-fos gene expression in the brain during morphine dependence and precipitated withdrawal, and phenotypic identification of the striatal neurons involved. (Q49144371) (← links)
- NIDA's medication development priorities in response to the Opioid Crisis: ten most wanted. (Q64977613) (← links)
- "Blockade of nitric oxide overproduction and oxidative stress by Nigella sativa oil attenuates morphine-induced tolerance" by Abdel-Zaher et al (Q83436450) (← links)
- N-acetylcysteine mitigates acute opioid withdrawal behaviors and CNS oxidative stress in neonatal rats (Q92629523) (← links)